Newsletters
Rowinski Group Awarded National Re-Certification by the Women’s Business Enterprise National Council
February 2021
Rowinski Group LLC, a reimbursement and healthcare payer data analytics consultancy for medical device, diagnostics, and digital health companies is proud to announce the firm was re-certified as a Women’s Business Enterprise (WBE).
Permanent Changes to Medicare Reimbursement for Clinicians
August 2020
We believe Medicare's Quality Payment Program may provide an opportunity to monetize your medical device, digital health technology, or diagnostic test in the absence of fee-for-service reimbursement. Medicare has set the standard for reimbursement based on healthcare providers delivering quality clinical care. This standard is under consideration by other U.S. health insurance payers.
CMS Recommends the Re-Opening of U.S. Facilities Under COVID-19
April 2020
Why this Newsletter? To understand how the decisions and policies made by the Centers for Medicare and Medicaid Services (CMS) can affect a company's revenue, especially under the current and future COVID-19 environment. To demonstrate this point, this Newsletter summarizes key points from a recent CMS recommendation to reverse a prior position to delay elective procedures and surgeries.
Opportunity for Start-Up Funding
March 2020
The University of California-San Francisco (UCSF) Rosenman Institute provides startups with expertise and mentorship from stakeholders across the healthcare industry. The Institute is inviting (40) startups to pitch on May 5 or 6, 2020 to a panel of judges comprised of financial/strategic investors, subject matter experts, and clinicians. The judges will select (10) startups as the 2020 Rosenman Innovators.
Rowinski Group Awarded National Certification from the Women’s Business Enterprise National Council
January 2020
Rowinski Group LLC, a reimbursement and healthcare payer data analytics consultancy for medical device, diagnostic and digital health companies, is proud to announce it was awarded national certification as a Women’s Business Enterprise (WBE).
As a certified Women’s Business Enterprise, Rowinski Group can assist U.S. based companies to meet their supplier diversity goals and objectives. The certification is effective January 1, 2020 and confirms Rowinski Group is at least 51% owned, operated, and controlled by women.
A Medicare Program to Reduce Procedure Volumes
July 2019
We believe it is important for companies to understand how payers' decisions and policies can affect revenue prospects. To demonstrate this point, this newsletter summarizes key points for a new Medicare program designed to affect imaging and therapeutic procedure volumes.
Opportunity for Start-Up Funding
February 2019
The University of California-San Francisco (UCSF) Rosenman Institute provides startups with expertise and mentorship from stakeholders across the healthcare industry. The Institute is inviting (40) startups to pitch on May 14 or 15, 2019 to a panel of judges comprised of financial/strategic investors, subject matter experts, and clinicians. The judges will select (10) startups as the 2019 Rosenman Innovators.
FDA Continues to Create More Communication Pathways Between Payors and Companies
September 2018
Rowinski Group considers the Federal Food and Drug Administration‘s (FDA) efforts to facilitate communication pathways between medical technology companies and payors relevant because the pathways may offer companies opportunities to begin reimbursement planning for their medical or digital technology well before it is cleared or approved by the FDA.